Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Boden

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|September 1, 1986
No increase in serum digoxin concentration with high-dose diltiazemW E Boden, G More, S Sharma, et al.
The American Journal of Cardiology|March 1, 1990
Effects of transdermal scopolamine on heart rate variability in normal subjectsT Vybiral, R J Bryg, M E Maddens, et al.
Circulation|February 1, 1990
Lack of diurnal variation in the onset of non-Q wave infarctionN S Kleiman, K B Schechtman, P M Young, et al.
Circulation|March 1, 1989
ST segment shifts are poor predictors of subsequent Q wave evolution in acute myocardial infarction. A natural history study of early non-Q wave infarctionW E Boden, R S Gibson, K B Schechtman, et al.
The American Journal of Cardiology|April 1, 1987
Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depressionW E Boden, R E Kleiger, R S Gibson, et al.
American Heart Journal|May 1, 1992
The relationship between 1-year mortality and infarct location in patients with non-Q wave myocardial infarctionK B Schechtman, R E Kleiger, W E Boden, et al.
Journal of the American College of Cardiology|April 1, 1990
Differential risk patterns associated with 3 month as compared with 3 to 12 month mortality and reinfarction after non-Q wave myocardial infarction. The Diltiazem Reinfarction Study GroupK B Schechtman, R J Capone, R E Kleiger, et al.
Journal of the American Geriatrics Society|July 15, 1999
Comparison based on age of baseline electrocardiographic abnormalities in non-Q-wave myocardial infarction. VANQWISH Trial Research Investigators. Veterans Affairs Non-Q-Wave Infarction Strategies In-HospitalH G Stratmann, R E Kleiger, D R Ferry, et al.
The American Journal of Cardiology|June 1, 1995
Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research GroupW E Boden, R Scheldewaert, E G Walters, et al.
European Heart Journal|December 5, 2000
Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trialP S Heggunje, M J Wade, R A O'Rourke, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|September 1, 1986
No increase in serum digoxin concentration with high-dose diltiazemW E Boden, G More, S Sharma, et al.
The American Journal of Cardiology|March 1, 1990
Effects of transdermal scopolamine on heart rate variability in normal subjectsT Vybiral, R J Bryg, M E Maddens, et al.
Circulation|February 1, 1990
Lack of diurnal variation in the onset of non-Q wave infarctionN S Kleiman, K B Schechtman, P M Young, et al.
Circulation|March 1, 1989
ST segment shifts are poor predictors of subsequent Q wave evolution in acute myocardial infarction. A natural history study of early non-Q wave infarctionW E Boden, R S Gibson, K B Schechtman, et al.
The American Journal of Cardiology|April 1, 1987
Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depressionW E Boden, R E Kleiger, R S Gibson, et al.
American Heart Journal|May 1, 1992
The relationship between 1-year mortality and infarct location in patients with non-Q wave myocardial infarctionK B Schechtman, R E Kleiger, W E Boden, et al.
Journal of the American College of Cardiology|April 1, 1990
Differential risk patterns associated with 3 month as compared with 3 to 12 month mortality and reinfarction after non-Q wave myocardial infarction. The Diltiazem Reinfarction Study GroupK B Schechtman, R J Capone, R E Kleiger, et al.
Journal of the American Geriatrics Society|July 15, 1999
Comparison based on age of baseline electrocardiographic abnormalities in non-Q-wave myocardial infarction. VANQWISH Trial Research Investigators. Veterans Affairs Non-Q-Wave Infarction Strategies In-HospitalH G Stratmann, R E Kleiger, D R Ferry, et al.
The American Journal of Cardiology|June 1, 1995
Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research GroupW E Boden, R Scheldewaert, E G Walters, et al.
European Heart Journal|December 5, 2000
Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trialP S Heggunje, M J Wade, R A O'Rourke, et al.
Pageof 7